Purpose
|
Amisulpride (trade name Solian) is an antipsychotic drug sold by Sanofi-Aventis. It is not approved for use in the United States, but is approved for use in Europe and Australia for the treatment of psychoses and schizophrenia. Additionally, it is approved in Italy for the treatment of dysthymia (under the brand name Deniban). Amisulpride is a selective dopamine antagonist.
|
Characteristics
|
Tradename: DENIBAN Source of Compound: synthetic Target: Dopamine Receptor antagonist,5-HT receptor antagonist Receptor: Dopamine receptor,5-HT receptor Status: INN, BAN
|
Purification
|
All the products are sent with COA, HPLC and NMR inspection report to guarantee the quality.
|
Purity
|
99?%
|
Formula
|
C17H27N3O4S
|
Solubility
|
DMSO 74 mg/mL , Water <1 74="" mg="" ml="" ,="" ethanol="" <="" td="">
1> |